Veru Inc. VERU
NASDAQ VERU
$2.14 +0.02 (+0.94%)
At close: Nov 11, 2026 · 4:00 PM EST

Veru (VERU) Accumulated Expenses (2009 - 2023)

Updated

Veru (VERU) reported Accumulated Expenses of $100,000 for fiscal Q4 2023 (quarter ended Sep 30, 2023).

Analysis

Veru (VERU) Accumulated Expenses (2009 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Veru 48.87 Mn -61.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 100,000.00
Jun 30, 2023 2.04 Mn
Mar 31, 2023 13.79 Mn
Dec 31, 2022 12.68 Mn
Sep 30, 2022 6.35 Mn
Jun 30, 2022 10.72 Mn
Mar 31, 2022 4.41 Mn
Dec 31, 2021 2.18 Mn
Sep 30, 2021 2.02 Mn
Jun 30, 2021 2.33 Mn
Mar 31, 2021 1.10 Mn
Dec 31, 2020 1.86 Mn
Sep 30, 2020 934,110.00
Jun 30, 2020 2.28 Mn
Mar 31, 2020 2.20 Mn
Dec 31, 2019 2.64 Mn
Sep 30, 2019 2.48 Mn
Jun 30, 2019 1.46 Mn
Mar 31, 2019 437,928.00
Dec 31, 2018 569,873.00
API Access

Veru Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=VERU&period=max&api_key=YOUR_API_KEY